Comparison of 3 Upper Tract Anticarcinogenic Agent Delivery Techniques in an Ex Vivo Porcine Model
Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine...
Saved in:
Published in | Urology (Ridgewood, N.J.) Vol. 82; no. 6; pp. 1451.e1 - 1451.e6 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.12.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Results Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively ( P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively ( P = .023). Conclusion Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma. |
---|---|
AbstractList | To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma.
An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining.
Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023).
Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma. To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023). Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma. Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma. Materials and Methods An indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining. Results Mean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively ( P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively ( P = .023). Conclusion Our results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma. OBJECTIVETo evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver topical anticarcinogenic agents in patients with upper tract urothelial carcinoma.MATERIALS AND METHODSAn indigo carmine solution was infused into en bloc porcine urinary tracts to test the 3 techniques: antegrade infusion via nephrostomy tube, reflux via indwelling double-pigtail stent, and retrograde administration via a 5F open-ended ureteral catheter. Nine renal units (3 per delivery method) were used. After a 1-hour dwell time, the urinary tracts were bivalved and photographed. Each renal unit was evaluated by 3 blinded reviewers who estimated the total percentage of stained urothelial surface area using a computer-based area approximation system. In addition, as a surrogate for exposure adequacy, a validated equation was used to calculate the staining intensity at 6 predetermined locations in the upper tract, with lower values representing more efficient staining.RESULTSMean percent of surface area stained for the nephrostomy tube, double-pigtail stent, and open-ended ureteral catheter groups was 65.2%, 66.2%, and 83.6%, respectively (P = .002). Mean staining intensities were 40.9, 33.4, and 20.4, respectively (P = .023).CONCLUSIONOur results suggest that retrograde infusion via open-ended ureteral catheter is the most efficient method of upper tract therapy delivery. Larger studies using in vivo models should be performed to further validate these findings and potentially confirm this method as optimal for delivery of topical anticarcinogenic agents in upper tract urothelial carcinoma. |
Author | Gupta, Mantu Cha, Doh Y Pollard, Matthew E Small, Alex C Badani, Ketan K Levinson, Adam W Shapiro, Edan Y Mohamed, Nihal E |
Author_xml | – sequence: 1 fullname: Pollard, Matthew E – sequence: 2 fullname: Levinson, Adam W – sequence: 3 fullname: Shapiro, Edan Y – sequence: 4 fullname: Cha, Doh Y – sequence: 5 fullname: Small, Alex C – sequence: 6 fullname: Mohamed, Nihal E – sequence: 7 fullname: Badani, Ketan K – sequence: 8 fullname: Gupta, Mantu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24139525$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFRwB5ySbh-i9xNqDRUFqkIpCYsrVc507xkLGDnYyYt-FZeDISzcCCDauzOefee757Qc5CDEjIcwYlA1a92pZjil18OJQcmChBlyD1I7JgitdF0zTqjCwAGigkb9Q5uch5CwBVVdVPyDmXTDSKqwVxq7jrbfI5Bho3VNC7vsdE18m6gS7D4J1Nzof4gME7upxkoG-x83tMB7pG9zX47yNm6gO1gV79-PXzi99H-inOKaQfYovdU_J4Y7uMz056Se7eXa1XN8Xtx-v3q-Vt4SSHoVBCNIj3Em0rdM21rbGSdeVaLaY6snJOMasqVTttW-SoLNQahNuoVtagKnFJXh7n9inORw1m57PDrrMB45gNk5XUWjcgJ6s6Wl2KOSfcmD75nU0Hw8DMfM3WnPiama8BbSa-U-7FacV4v8P2b-oP0Mnw5mjAqejeYzLZeQwOW5_QDaaN_r8rXv8zwXV-gm-7b3jAvI1jChNFw0zmBszn-cnzj5kAxgRn4jcLVKX0 |
CitedBy_id | crossref_primary_10_1590_s1677_5538_ibju_2016_0258 crossref_primary_10_1016_j_urology_2018_02_004 crossref_primary_10_3389_fruro_2022_916259 crossref_primary_10_1007_s00120_018_0830_0 crossref_primary_10_1016_j_urology_2016_09_039 crossref_primary_10_1080_17512433_2018_1461560 crossref_primary_10_1007_s00345_019_02811_w crossref_primary_10_1089_end_2016_0871 crossref_primary_10_1016_j_urolonc_2019_02_004 crossref_primary_10_1016_j_urolonc_2020_08_002 crossref_primary_10_1089_end_2020_0293 crossref_primary_10_1080_14737140_2017_1326823 crossref_primary_10_1016_j_ucl_2017_12_009 crossref_primary_10_3233_BLC_220093 |
Cites_doi | 10.1002/1097-0142(19850315)55:6<1422::AID-CNCR2820550642>3.0.CO;2-F 10.1016/j.eururo.2011.07.051 10.1046/j.1464-410X.2001.02297.x 10.1089/end.2007.9969 10.1016/j.eururo.2010.12.042 10.1046/j.1464-410x.2000.00610.x 10.1016/j.eururo.2004.01.021 10.1046/j.1464-410X.1996.09559.x 10.1016/j.urology.2004.01.046 10.1016/S0090-4295(99)80005-3 10.1191/096228000701555262 10.1038/ncpuro0250 10.1111/j.1442-2042.2006.01312.x 10.1016/j.eururo.2011.03.017 10.1016/j.urology.2008.06.026 10.1016/S0090-4295(01)01488-1 10.1111/j.1464-410X.2012.11066.x 10.1046/j.1442-2042.2002.00551.x |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2013 Elsevier Inc. Copyright © 2013 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Elsevier Inc. – notice: 2013 Elsevier Inc. – notice: Copyright © 2013 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.urology.2013.08.048 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-9995 |
EndPage | 1451.e6 |
ExternalDocumentID | 10_1016_j_urology_2013_08_048 24139525 S0090429513011321 1_s2_0_S0090429513011321 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- --K --M -RU .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAEJM AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXKI AAXUO ABBQC ABFNM ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACIUM ACRLP ACRZS ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJJEV AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IHE J1W KOM L7B LZ2 M29 M41 MO0 N9A O-L O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SPCBC SSH SSZ T5K UV1 WH7 WOW WUQ X7M XPP Z5R ZGI ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c420t-5339eeb4ead38728a7e6476cd8399546cc51a5657c8ade2e5a07803cf5d470563 |
IEDL.DBID | AIKHN |
ISSN | 0090-4295 |
IngestDate | Fri Oct 25 22:52:56 EDT 2024 Thu Sep 26 18:39:00 EDT 2024 Sat Sep 28 07:52:57 EDT 2024 Fri Feb 23 02:27:29 EST 2024 Tue Oct 15 22:55:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Copyright © 2013 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c420t-5339eeb4ead38728a7e6476cd8399546cc51a5657c8ade2e5a07803cf5d470563 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24139525 |
PQID | 1464888904 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_1464888904 crossref_primary_10_1016_j_urology_2013_08_048 pubmed_primary_24139525 elsevier_sciencedirect_doi_10_1016_j_urology_2013_08_048 elsevier_clinicalkeyesjournals_1_s2_0_S0090429513011321 |
PublicationCentury | 2000 |
PublicationDate | 2013-12-01 |
PublicationDateYYYYMMDD | 2013-12-01 |
PublicationDate_xml | – month: 12 year: 2013 text: 2013-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Urology (Ridgewood, N.J.) |
PublicationTitleAlternate | Urology |
PublicationYear | 2013 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Treuthardt, Danuser, Studer (bib28) 2004; 46 Rastinehad, Ost, Vanderbrink (bib8) 2009; 73 Vasavada, Streem, Novick (bib6) 1995; 45 Hayashida, Nomata, Noguchi (bib12) 2004; 63 Nelson, Pepe (bib21) 2000; 9 Huffman, Bagley, Lyon (bib2) 1985; 15 Kojima, Tozawa, Kawai (bib15) 2006; 13 Nishino, Yamamoto, Komeda (bib18) 2000; 85 Hall, Chang, Dalbagni (bib25) 2007; 178 Jarrett, Sweetser, Weiss (bib5) 1995; 154 Monson, Wein, McKenna (bib30) 1991; 145 Guarnizo, Pavlovich, Seiba (bib22) 2000; 163 Roupret, Zigeuner, Palou (bib1) 2011; 59 Miyake, Eto, Hara (bib11) 2002; 9 Huffman, Morse, Herr (bib4) 1985; 26 Yokogi, Wada, Mizutani (bib10) 1996; 77 Grasso, Fishman, Cohen (bib24) 2012; 110 Pereira-Sampaio, Favorito, Sampaio (bib19) 2004; 172 Schnapp, Weiss, Smith (bib29) 1996; 156 Gadzinski, Roberts, Faerber (bib23) 2010; 183 Babjuk, Oosterlinck, Sylvester (bib26) 2011; 59 Ost, Vanderbrink, Lee (bib3) 2005; 2 Yossepowitch, Lifshitz, Dekel (bib27) 2005; 173 Thalmann, Markwalder, Walter (bib7) 2002; 168 Katz, Lee, Gupta (bib17) 2007; 21 Giannarini, Kessler, Birkhauser (bib9) 2011; 60 Patel, Fuchs (bib13) 1998; 159 Bass (bib20) 2010 Okubo, Ichioka, Terada (bib16) 2001; 88 Irie, Iwamura, Kadowaki (bib14) 2002; 59 Yokogi (10.1016/j.urology.2013.08.048_bib10) 1996; 77 Kojima (10.1016/j.urology.2013.08.048_bib15) 2006; 13 Roupret (10.1016/j.urology.2013.08.048_bib1) 2011; 59 Hall (10.1016/j.urology.2013.08.048_bib25) 2007; 178 Monson (10.1016/j.urology.2013.08.048_bib30) 1991; 145 Nishino (10.1016/j.urology.2013.08.048_bib18) 2000; 85 Giannarini (10.1016/j.urology.2013.08.048_bib9) 2011; 60 Nelson (10.1016/j.urology.2013.08.048_bib21) 2000; 9 Katz (10.1016/j.urology.2013.08.048_bib17) 2007; 21 Babjuk (10.1016/j.urology.2013.08.048_bib26) 2011; 59 Gadzinski (10.1016/j.urology.2013.08.048_bib23) 2010; 183 Treuthardt (10.1016/j.urology.2013.08.048_bib28) 2004; 46 Rastinehad (10.1016/j.urology.2013.08.048_bib8) 2009; 73 Grasso (10.1016/j.urology.2013.08.048_bib24) 2012; 110 Thalmann (10.1016/j.urology.2013.08.048_bib7) 2002; 168 Schnapp (10.1016/j.urology.2013.08.048_bib29) 1996; 156 Yossepowitch (10.1016/j.urology.2013.08.048_bib27) 2005; 173 Huffman (10.1016/j.urology.2013.08.048_bib2) 1985; 15 Patel (10.1016/j.urology.2013.08.048_bib13) 1998; 159 Bass (10.1016/j.urology.2013.08.048_bib20) 2010 Irie (10.1016/j.urology.2013.08.048_bib14) 2002; 59 Vasavada (10.1016/j.urology.2013.08.048_bib6) 1995; 45 Pereira-Sampaio (10.1016/j.urology.2013.08.048_bib19) 2004; 172 Ost (10.1016/j.urology.2013.08.048_bib3) 2005; 2 Miyake (10.1016/j.urology.2013.08.048_bib11) 2002; 9 Huffman (10.1016/j.urology.2013.08.048_bib4) 1985; 26 Hayashida (10.1016/j.urology.2013.08.048_bib12) 2004; 63 Guarnizo (10.1016/j.urology.2013.08.048_bib22) 2000; 163 Jarrett (10.1016/j.urology.2013.08.048_bib5) 1995; 154 Okubo (10.1016/j.urology.2013.08.048_bib16) 2001; 88 |
References_xml | – volume: 9 start-page: 677 year: 2002 end-page: 680 ident: bib11 article-title: Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract publication-title: Int J Urol contributor: fullname: Hara – volume: 45 start-page: 381 year: 1995 end-page: 386 ident: bib6 article-title: Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys publication-title: Urology contributor: fullname: Novick – volume: 178 start-page: 2314 year: 2007 end-page: 2330 ident: bib25 article-title: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update publication-title: J Urol contributor: fullname: Dalbagni – volume: 21 start-page: 374 year: 2007 end-page: 377 ident: bib17 article-title: Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B publication-title: J Endourol contributor: fullname: Gupta – volume: 63 start-page: 1084 year: 2004 end-page: 1088 ident: bib12 article-title: Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract publication-title: Urology contributor: fullname: Noguchi – volume: 88 start-page: 343 year: 2001 end-page: 347 ident: bib16 article-title: Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure publication-title: BJU Int contributor: fullname: Terada – volume: 183 start-page: 2148 year: 2010 end-page: 2153 ident: bib23 article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma publication-title: J Urol contributor: fullname: Faerber – year: 2010 ident: bib20 article-title: Handbook of Optics Volume III - Vision and Vision Optics: Chapter 10: Colorimetry contributor: fullname: Bass – volume: 59 start-page: 53 year: 2002 end-page: 57 ident: bib14 article-title: Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter publication-title: Urology contributor: fullname: Kadowaki – volume: 13 start-page: 340 year: 2006 end-page: 344 ident: bib15 article-title: Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy publication-title: Int J Urol contributor: fullname: Kawai – volume: 156 start-page: 386 year: 1996 end-page: 388 ident: bib29 article-title: Fever following intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma publication-title: J Urol contributor: fullname: Smith – volume: 2 start-page: 376 year: 2005 end-page: 383 ident: bib3 article-title: Endourologic treatment of upper urinary tract transitional cell carcinoma publication-title: Nat Clin Pract Urol contributor: fullname: Lee – volume: 172 start-page: 2077 year: 2004 end-page: 2081 ident: bib19 article-title: Pig kidney: anatomical relationships between the intrarenal arteries and the kidney collecting system. applied study for urological research and surgical training publication-title: J Urol contributor: fullname: Sampaio – volume: 154 start-page: 1629 year: 1995 end-page: 1635 ident: bib5 article-title: Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience publication-title: J Urol contributor: fullname: Weiss – volume: 15 start-page: 1422 year: 1985 end-page: 1428 ident: bib2 article-title: Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report publication-title: Cancer contributor: fullname: Lyon – volume: 46 start-page: 442 year: 2004 end-page: 443 ident: bib28 article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis publication-title: Eur Urol contributor: fullname: Studer – volume: 77 start-page: 676 year: 1996 end-page: 679 ident: bib10 article-title: Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract publication-title: Br J Urol contributor: fullname: Mizutani – volume: 59 start-page: 997 year: 2011 end-page: 1008 ident: bib26 article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update publication-title: Eur Urol contributor: fullname: Sylvester – volume: 145 start-page: 842 year: 1991 end-page: 845 ident: bib30 article-title: Indigocarmine as a quantitative indicator of urothelial integrity publication-title: J Urol contributor: fullname: McKenna – volume: 26 start-page: 47 year: 1985 end-page: 50 ident: bib4 article-title: Consideration for treatment of upper urinary tract tumors with topical therapy publication-title: Urology contributor: fullname: Herr – volume: 60 start-page: 955 year: 2011 end-page: 960 ident: bib9 article-title: Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? publication-title: Eur Urol contributor: fullname: Birkhauser – volume: 168 start-page: 1381 year: 2002 end-page: 1385 ident: bib7 article-title: Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery publication-title: J Urol contributor: fullname: Walter – volume: 73 start-page: 27 year: 2009 end-page: 31 ident: bib8 article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy? publication-title: Urology contributor: fullname: Vanderbrink – volume: 163 start-page: 52 year: 2000 end-page: 55 ident: bib22 article-title: Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach publication-title: J Urol contributor: fullname: Seiba – volume: 9 start-page: 475 year: 2000 end-page: 496 ident: bib21 article-title: Statistical description of interrater variability in ordinal ratings publication-title: Stat Methods Med Res contributor: fullname: Pepe – volume: 159 start-page: 71 year: 1998 end-page: 75 ident: bib13 article-title: New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma publication-title: J Urol contributor: fullname: Fuchs – volume: 110 start-page: 1618 year: 2012 end-page: 1626 ident: bib24 article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients publication-title: BJU Int contributor: fullname: Cohen – volume: 173 start-page: 890 year: 2005 end-page: 893 ident: bib27 article-title: Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation publication-title: J Urol contributor: fullname: Dekel – volume: 85 start-page: 799 year: 2000 end-page: 801 ident: bib18 article-title: Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract publication-title: BJU Int contributor: fullname: Komeda – volume: 59 start-page: 584 year: 2011 end-page: 594 ident: bib1 article-title: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update publication-title: Eur Urol contributor: fullname: Palou – volume: 15 start-page: 1422 year: 1985 ident: 10.1016/j.urology.2013.08.048_bib2 article-title: Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report publication-title: Cancer doi: 10.1002/1097-0142(19850315)55:6<1422::AID-CNCR2820550642>3.0.CO;2-F contributor: fullname: Huffman – volume: 60 start-page: 955 year: 2011 ident: 10.1016/j.urology.2013.08.048_bib9 article-title: Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? publication-title: Eur Urol doi: 10.1016/j.eururo.2011.07.051 contributor: fullname: Giannarini – volume: 88 start-page: 343 year: 2001 ident: 10.1016/j.urology.2013.08.048_bib16 article-title: Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure publication-title: BJU Int doi: 10.1046/j.1464-410X.2001.02297.x contributor: fullname: Okubo – volume: 21 start-page: 374 year: 2007 ident: 10.1016/j.urology.2013.08.048_bib17 article-title: Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B publication-title: J Endourol doi: 10.1089/end.2007.9969 contributor: fullname: Katz – volume: 59 start-page: 584 year: 2011 ident: 10.1016/j.urology.2013.08.048_bib1 article-title: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update publication-title: Eur Urol doi: 10.1016/j.eururo.2010.12.042 contributor: fullname: Roupret – volume: 85 start-page: 799 year: 2000 ident: 10.1016/j.urology.2013.08.048_bib18 article-title: Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract publication-title: BJU Int doi: 10.1046/j.1464-410x.2000.00610.x contributor: fullname: Nishino – volume: 46 start-page: 442 year: 2004 ident: 10.1016/j.urology.2013.08.048_bib28 article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis publication-title: Eur Urol doi: 10.1016/j.eururo.2004.01.021 contributor: fullname: Treuthardt – volume: 178 start-page: 2314 year: 2007 ident: 10.1016/j.urology.2013.08.048_bib25 article-title: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update publication-title: J Urol contributor: fullname: Hall – volume: 77 start-page: 676 year: 1996 ident: 10.1016/j.urology.2013.08.048_bib10 article-title: Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract publication-title: Br J Urol doi: 10.1046/j.1464-410X.1996.09559.x contributor: fullname: Yokogi – volume: 63 start-page: 1084 year: 2004 ident: 10.1016/j.urology.2013.08.048_bib12 article-title: Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract publication-title: Urology doi: 10.1016/j.urology.2004.01.046 contributor: fullname: Hayashida – volume: 45 start-page: 381 year: 1995 ident: 10.1016/j.urology.2013.08.048_bib6 article-title: Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys publication-title: Urology doi: 10.1016/S0090-4295(99)80005-3 contributor: fullname: Vasavada – volume: 163 start-page: 52 year: 2000 ident: 10.1016/j.urology.2013.08.048_bib22 article-title: Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach publication-title: J Urol contributor: fullname: Guarnizo – volume: 172 start-page: 2077 year: 2004 ident: 10.1016/j.urology.2013.08.048_bib19 article-title: Pig kidney: anatomical relationships between the intrarenal arteries and the kidney collecting system. applied study for urological research and surgical training publication-title: J Urol contributor: fullname: Pereira-Sampaio – volume: 9 start-page: 475 year: 2000 ident: 10.1016/j.urology.2013.08.048_bib21 article-title: Statistical description of interrater variability in ordinal ratings publication-title: Stat Methods Med Res doi: 10.1191/096228000701555262 contributor: fullname: Nelson – volume: 159 start-page: 71 year: 1998 ident: 10.1016/j.urology.2013.08.048_bib13 article-title: New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma publication-title: J Urol contributor: fullname: Patel – volume: 156 start-page: 386 year: 1996 ident: 10.1016/j.urology.2013.08.048_bib29 article-title: Fever following intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma publication-title: J Urol contributor: fullname: Schnapp – volume: 2 start-page: 376 year: 2005 ident: 10.1016/j.urology.2013.08.048_bib3 article-title: Endourologic treatment of upper urinary tract transitional cell carcinoma publication-title: Nat Clin Pract Urol doi: 10.1038/ncpuro0250 contributor: fullname: Ost – volume: 13 start-page: 340 year: 2006 ident: 10.1016/j.urology.2013.08.048_bib15 article-title: Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy publication-title: Int J Urol doi: 10.1111/j.1442-2042.2006.01312.x contributor: fullname: Kojima – volume: 154 start-page: 1629 year: 1995 ident: 10.1016/j.urology.2013.08.048_bib5 article-title: Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience publication-title: J Urol contributor: fullname: Jarrett – volume: 59 start-page: 997 year: 2011 ident: 10.1016/j.urology.2013.08.048_bib26 article-title: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update publication-title: Eur Urol doi: 10.1016/j.eururo.2011.03.017 contributor: fullname: Babjuk – volume: 73 start-page: 27 year: 2009 ident: 10.1016/j.urology.2013.08.048_bib8 article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy? publication-title: Urology doi: 10.1016/j.urology.2008.06.026 contributor: fullname: Rastinehad – volume: 145 start-page: 842 year: 1991 ident: 10.1016/j.urology.2013.08.048_bib30 article-title: Indigocarmine as a quantitative indicator of urothelial integrity publication-title: J Urol contributor: fullname: Monson – volume: 59 start-page: 53 year: 2002 ident: 10.1016/j.urology.2013.08.048_bib14 article-title: Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter publication-title: Urology doi: 10.1016/S0090-4295(01)01488-1 contributor: fullname: Irie – volume: 173 start-page: 890 year: 2005 ident: 10.1016/j.urology.2013.08.048_bib27 article-title: Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation publication-title: J Urol contributor: fullname: Yossepowitch – volume: 183 start-page: 2148 year: 2010 ident: 10.1016/j.urology.2013.08.048_bib23 article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma publication-title: J Urol contributor: fullname: Gadzinski – volume: 110 start-page: 1618 year: 2012 ident: 10.1016/j.urology.2013.08.048_bib24 article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.11066.x contributor: fullname: Grasso – volume: 26 start-page: 47 year: 1985 ident: 10.1016/j.urology.2013.08.048_bib4 article-title: Consideration for treatment of upper urinary tract tumors with topical therapy publication-title: Urology contributor: fullname: Huffman – year: 2010 ident: 10.1016/j.urology.2013.08.048_bib20 contributor: fullname: Bass – volume: 9 start-page: 677 year: 2002 ident: 10.1016/j.urology.2013.08.048_bib11 article-title: Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract publication-title: Int J Urol doi: 10.1046/j.1442-2042.2002.00551.x contributor: fullname: Miyake – volume: 168 start-page: 1381 year: 2002 ident: 10.1016/j.urology.2013.08.048_bib7 article-title: Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery publication-title: J Urol contributor: fullname: Thalmann |
SSID | ssj0006667 |
Score | 2.241358 |
Snippet | Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality... To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally... To evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality to locally... OBJECTIVETo evaluate the degree of urothelial exposure using 3 upper tract delivery techniques in an ex vivo porcine model, to determine the optimal modality... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1451.e1 |
SubjectTerms | Administration, Topical Animals Anticarcinogenic Agents - administration & dosage Coloring Agents Disease Models, Animal Kidney Stents Swine Ureter Urinary Catheterization - methods Urinary Tract Urologic Neoplasms - drug therapy Urology Urothelium |
Title | Comparison of 3 Upper Tract Anticarcinogenic Agent Delivery Techniques in an Ex Vivo Porcine Model |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0090429513011321 https://dx.doi.org/10.1016/j.urology.2013.08.048 https://www.ncbi.nlm.nih.gov/pubmed/24139525 https://search.proquest.com/docview/1464888904 |
Volume | 82 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5SB0ovJX07acMGepUt7UOPo3ET3JSEHuyS27LaHYFCkIxlh-SS35Lfkl-WHWnlUNpSyFFCw0qzszOjmflmCPmaA3AdsyzQYcYCAZYHecJMANIWoS6MjNuA29l5PFuI0wt5sUOmPRYGyyq97u90equt_Z2x5-Z4WZaI8c1Qm8oIZZQjmHzXmSOWDsju5PuP2flWITsP3bfODAMkeALyjC9Hm1UbvsYiL94288RJQH83Uf9yQVtTdLJHXnsfkk6613xDdqB6S16e-Sz5O2Km2-GCtC4op4vlElZ0joAoOqkwer1yT9ZOdkpDJwiuot_gCis0bum8b-ra0LKiuqLHNw_3v8rrmv6skQoojk-7ek8WJ8fz6SzwwxQCI1i4DpxblwHkwkkOTxOW6gRikcTGpghuFbExMtKYAzWptsBAauc8hNwU0orEeUn8AxlUdQWfCM1CG4VFLphmRkhRaJEbzfPCxhaS3KZDMur5p5ZdzwzVF5NdKs9whQxXOAJTOIKk57LqAaFOhUHjz1OjItUwFao_9nxI0i3lb2KjnEX436JH_X4qd6QwT6IrqDcN_g05tZa6lYbkY7fR2-_ANGQmmdx__sIH5BVedTUxn8lgvdrAF-fZrPND8mJ0Fx16-X0ELEf5QQ |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaKFth2Kbru0bTbqgG9unH08OMYZC3SR4IekqE3QZZowEVhB3FStP-mv2W_bKItZxi2YUCvtgnZFEV9FvmRhJxkAFxHLA10mLJAgOVBFjMTgLR5qHMjo-bAbTKNxnNxeStvt8io48JgWqX3_a1Pb7y1v9L32uwvigI5vil6UzlAG-VIJt9xaCB1q3NneHE1nm4cskPovnRmGKDALyJP_-50vWyOrzHJizfFPLET0N-3qH9B0GYrOt8jux5D0mH7mm_JFpT75NXER8nfETPaNBekVU45nS8WsKQzJETRYYmn10v3ZOVspzB0iOQq-g3uMUPjic66oq41LUqqS3r2-OP5e_FQ0ZsKpYBi-7T792R-fjYbjQPfTCEwgoWrwMG6FCATznJ4ErNExxCJODI2QXKriIyRA40xUJNoCwykduAh5CaXVsQOJfEPZLusSjggNA3tIMwzwTQzQopci8xonuU2shBnNumR005_atHWzFBdMtmd8gpXqHCFLTCFE4g7LauOEOpcGNR-PdVqoGqmQvXHnPdIspH8zWyU2xH-N-jXbj6VW1IYJ9ElVOsa_4acW0vcSD3ysZ3ozXdgGDKVTB6-fOBj8no8m1yr64vp1RF5g3fa_JhPZHu1XMNnh3JW2RdvxT8BM9b7NQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+3+upper+tract+anticarcinogenic+agent+delivery+techniques+in+an+ex+vivo+porcine+model&rft.jtitle=Urology+%28Ridgewood%2C+N.J.%29&rft.au=Pollard%2C+Matthew+E&rft.au=Levinson%2C+Adam+W&rft.au=Shapiro%2C+Edan+Y&rft.au=Cha%2C+Doh+Y&rft.date=2013-12-01&rft.eissn=1527-9995&rft.volume=82&rft.issue=6&rft.spage=1451.e1&rft.epage=1451.e6&rft_id=info:doi/10.1016%2Fj.urology.2013.08.048&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00904295%2FS0090429513X00111%2Fcov150h.gif |